Additional risk factors identified by the ADA are as follows: (1) the use of glucocorticoids, statins, proprotein convertase subtilisin kexin 9 inhibitors, thiazide diuretics, some anti-psychotic medications, such as olanzapine, and medications for human immunodeficiency virus infection, (2) genetic causes for maturity-onset diabetes in the young (MODY) (<35 years of age) due to genetic mutations in the hepatic nuclear factor 1 and 4 alpha or HNF1A and HNF1B genes and the glucokinase or GCK gene, and (3) autoimmunity in childhood diabetes [1]. Here, GCK is linked to type 2 diabetes mellitus.